Note: This event is free and open to all. If you would like to attend please RSVP to Champa Heidbrink at [log in to unmask] . Confirmations in response to RSVPs will be sent out fortnightly.


David McDaid
LSE Health and Social Care

Merck Trust Lecture 2005/06
LSE Health

Health technology assessment: has the UK got it right?

Several jurisdictions have established agencies for the assessment of health technologies. In some countries the recommendations of such agencies are purely advisory, in others they are linked to decision-making procedures concerning the price, reimbursement or use of health technologies.

In the UK the government has established the National Coordinating Centre for Health Technology Assessment and constituent parts of the UK have bodies that make recommendations about the use of drugs or other health technologies, such as the National Institute for Health and Clinical Excellence (NICE) in England.

The adoption of these procedures has raised many challenging methodological and policy issues. These include: (i) how to prioritise technologies for appraisal; (ii) how to involved stakeholders; (iii) how to develop the necessary technical skills; (iv) how to implement the findings of studies?

This presentation will give an assessment of the progress made in the UK by comparing and contrasting with experience in other countries. Also, where relevant, experience in different parts of the UK will be compared.

Date: Friday, 10 March 2006
Time: 6.00pm
Venue: Old Theatre, Old Building.
Speaker: Professor Michael Drummond, Centre for Health Economics, University of York

Professor Michael Drummond is Professor of Health Economics and former Director of the Centre for Health Economics at the University of York. His particular field of interest is in the economic evaluation of health care treatments and programmes. He has undertaken evaluations in a wide range of medical fields including care of the elderly, neonatal intensive care, immunization programmes, services for people with AIDS, eye health care and pharmaceuticals. He is the author of two major textbooks and more than 500 scientific papers, has acted as a consultant to the World Health Organization and was Project Leader of a European Union Project on the Methodology of Economic Appraisal of Health Technology. He has been President of the International Society of Technology Assessment in Health Care, and a board member of the International Society for Pharmacoeconomics and Outcomes Research. He is currently a member of the Guidelines Review Panels of the National Institute for Clinical Excellence (NICE) in the UK, and is also Vice-President (European Operations) of Innovus Research Inc. From July 2006 he will be President of the International Society for Pharmacoeconomics and Outcomes Research.
This event is free and open to all. If you would like to attend please RSVP to Champa Heidbrink at [log in to unmask] . Confirmations in response to RSVPs will be sent out fortnightly.